Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-04-028436
Filing Date
2004-05-27
Accepted
2004-05-27 18:40:10
Documents
2
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bob50698vm.html 3  
1 MAIN DOCUMENT DESCRIPTION bob50698vm.xml 3 5783
2 POWER OF ATTORNEY vm-poa.txt EX-24 4555
  Complete submission text file 0001209191-04-028436.txt   12172
Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 617-252-0700
Miles Vincent J (Reporting) CIK: 0001291966 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 04836240